Abstract
Intraperitoneal administration ofm-chlorophenylpiperazine (m-CPP) to Wistar rats produced hyperthermia with a peak effect at 30 min. Pretreatment with low doses of metergoline (5-HT1/5-HT2 antagonist), mesulergine and mianserin (5-HT2C/5-HT2A antagonists) blockedm-CPP-induced hyperthermia. Pretreatment with propranolol (β-adrenergic receptor antagonist that also has binding affinity for 5-HT1A, 5-HT1B and 5-HT2B sites), yohimbine (α2-noradrenergic antagonist that also has binding affinity for 5-HT2B sites), MDL-72222 or ondansetron (5-HT3 antagonists) did not attenuatem-CPP-induced hyperthermia. Only high doses of ketanserin, LY-53857 and ritanserin (5-HT2A/5-HT2C antagonists) as well as spiperone (5-HT1A/5-HT2A/D2 antagonist) attenuatedm-CPP-induced hyperthermia. Daily administration ofm-CPP produced complete tolerance to its hyperthermic effect by day 5. However, there was no cross-tolerance to 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI, a 5-HT2A agonist that also has high affinity for 5-HT2C receptors)-induced hyperthermia.m-CPP-induced increases in temperature were found to be significantly less in the Fawn-Hooded (FH) rat strain as compared to the Wistar rat strain; in prior studies, FH rats have been found to be subsensitive to other 5-HT2C-mediated pharmacologic responses. Altogether, these findings suggest thatm-CPP-induced hyperthermia in rats is mediated by selective stimulation of 5-HT2C receptors.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Aulakh CS, Wozniak KM, Hill JL, DeVane CL, Tolliver TJ, Murphy DL (1988) Differential neuroendocrine responses to the 5-HT agonistm-chlorophenylpiperazine in Fawn-Hooded rats relative to Wistar and Sprague-Dawley rats. Neuroendocrinology 48: 401–406
Aulakh CS, Hill JL, Murphy DL (1989) A comparison of feeding and locomotion responses to serotonin agonists in three rat strains. Pharmacol Biochem Behav 31: 567–571
Aulakh CS, Hill JL, Lesch KP, Murphy DL (1992a) Functional subsensitivity of 5-hydroxytryptamine1C or alpha2-adrenergic heteroreceptors mediating clonidine-induced growth hormone release in the Fawn-Hooded rat strain relative to the Wistar rat strain. J Pharmacol Exp Ther 262: 1038–1043
Aulakh CS, Hill JL, Murphy DL (1992b) Effects of various serotonin receptor subtype selective antagonists alone and onm-CPP-induced neuroendocrine changes in rats. J Pharmacol Exp Ther 263: 588–595
Aulakh CS, Mazzola-Pomietto P, Wozniak K, Hill J, Murphy DL (1994) Evidence that 1-(2,5-dimethoxy-4-methylphenyl)-2-aminopropane (DOM)-induced hypophagia and hyperthermia in rats is mediated by 5-HT2A receptors. J Pharmacol Exp Ther 270: 127–132
Berendsen HHG, Jenck F, Broekkamp CLE (1990) Involvement of 5-HT1C receptors in drug-induced penile erections in rats. Psychopharmacology 101: 57–61
Butler A, Hill JM, Ireland SJ, Jordan CC, Tyers MB (1988) Pharmacological properties of GR38032F, a novel antagonist at 5-HT3 receptors. Br J Pharmacol 94: 397–412
Caccia S, Ballabio M, Samanin R, Zanini MG, Garattini S (1981) (-)-m-Chlorophenyl-piperazine, a central 5-hydroxytryptamine agonist, is a metabolite of trazodone. J Pharm Pharmacol 33: 477–478
Callahan PM, Cunningham KA (1994) Involvement of 5-HT2C receptors in mediating the discriminative stimulus properties ofm-chlorophenylpiperazine (m-CPP). Eur J Pharmacol 257: 27–38
Conn PJ, Sanders-Bush E (1987) Relative efficacies of piperazines at the phosphoinositide hydrolysis-linked serotonergic (5-HT2 and 5-HT1C) receptors. J Pharmacol Exp Ther 242: 552–557
Costall B, Domeney AM, Naylor RJ, Tyers MB (1987) Effects of the 5-HT3 receptor antagonist, Gr38032F, on raised dopaminergic activity in the mesolimbic system of the rat and marmoset brain. Br J Pharmacol 92: 881–894
Fiorella D, Rabin RA, Winter JC (1995) The role of the 5-HT2A and 5-HT2C receptors in the stimulus effects ofm-chlorophenylpiperazine. Psychopharmacology 119: 222–230
Fozard JR (1984) MDL-72222, a potent and highly selective antagonist at neuronal 5-hydroxytryptamine receptors. Naunyn-Schmiedeberg's Arch Pharmacol 326: 36–44
Fuller RW (1990) Serotonin receptors and neuroendocrine responses. Neuropsychopharmacology 3: 495–502
Gudelsky GA, Koenig JI, Meltzer HY (1985) Altered responses to serotonergic agents in Fawn-Hooded rats. Pharmacol Biochem Behav 22: 489–492
Gudelsky GA, Koenig JI, Meltzer HY (1986) Thermoregulatory responses to serotonin (5-HT) receptor stimulation in the rat. Neuropharmacology 25: 1307–1313
Hoyer D (1988) Functional correlates of serotonin 5-HT1 recognition sites. J Recept Res 8: 59–81
Hoyer D, Schoeffter P (1991) 5-HT receptors: subtypes and second messengers. J Recept Res 11: 197–214
Hoyer D, Clarke DE, Fozard JR, Hartig PR, Martin GR, Mylecharane EJ, Saxena PR, Humphrey PPA (1994) International union of pharmacology classification of receptors for 5-hydroxytryptamine (serotonin). Pharmacol Rev 46: 157–203
Hulihan-Giblin BA, Park YD, Aulakh CS, Goldman D (1992) Regional analysis of 5-HT1A and 5-HT2 receptors in the Fawn-Hooded rat. Neuropharmacology 31: 1095–1099
Hulihan-Giblin BA, Park YD, Goldman D, Aulakh CS (1993) Analysis of the 5-HT1C receptor and the serotonin uptake site in Fawn-Hooded rat brain. Eur J Pharmacol 239: 99–102
Humphrey PPA, Hartig P, Hoyer D (1993) A proposed new nomenclature for 5-HT receptors. Trends Pharmacol Sci 14: 233–236
Kalkman HO, Fozard JR (1991) Serotonin: molecular biology, receptors and functional effects. Birkhauser, Basel
Kennett GA (1993) 5-HT1C receptors and their therapeutic relevance. Curr Opin Invest Drugs 2: 317–362
Kennett GA, Curzon G (1988) Evidence thatm-CPP may have behavioral effects mediated by central 5-HT1C receptors. Br J Pharmacol 94: 137–147
Kennett GA, Curzon G (1991) Potencies of antagonists indicate that 5-HT1C receptors mediate 1-3(chlorophenyl)piperazine-induced hypophagia. Br J Pharmacol 103: 2016–2020
Klodzinska A, Chojnacka-Wojcik E (1992) Hyperthermia induced bym-trifluoromethylphenylpiperazine (TFMPP) orm-chlorophenylpiperazine (m-CPP) in heat-adapted rats. Psychopharmacology 109: 466–472
Mazzola-Pomietto P, Aulakh CS, Wozniak KM, Hill JL, Murphy DL (1995) Evidence that 1-(2,5-di-methoxy-4-iodophenyl)-2-aminopropane (DOI)-induced hyperthermia in rats is mediated by stimulation of 5-HT2A receptors. Psychopharmacology 117: 193–199
Mueller EA, Murphy DL, Sunderland T (1985) Neuroendocrine effects ofm-chlorophenylpiperazine, a serotonin agonist, in humans. J Clin Endocrinol 61: 1179–1184
Murphy DL, Lesch KP, Aulakh CS, Pigott TA (1991) Serotonin-selective arylpiperazines with neuroendocrine, behavioral, temperature, and cardiovascular effects in humans. Pharmacol Rev 43: 527–552
Murphy DL, Mazzola-Pomietto P, Wozniak KM, Garrick NA, Hill JL, Aulakh CS (1993) Evidence that DOI-induced hyperthermia in rats is mediated by 5-HT2 receptors. Soc Neurosci Abstr 19: 1380
Nash JFJ, Meltzer HY, Gudelsky GA (1989) Selective cross-tolerance to 5-HT1A and 5-HT2 receptor-mediated temperature and corticosterone responses. Pharmacol Biochem Behav 33: 781–785
Pawlowski L (1984) Amitriptyline and femoxetine, but not clomipramine or citalopram, antagonize hyperthermia induced by directly acting 5-hydroxytryptamine-like drugs in heat adapted rats. J Pharm Pharmacol 36: 197–199
Pompeiano M, Palacios JM, Mengod G (1994) Distribution of the serotonin 5-HT2 receptor family mRNAs: comparison between 5-HT2A and 5-HT2C receptors. Mol Brain Res 23: 163–178
Pranzatelli MR (1990) Evidence for involvement of 5-HT2 and 5-HT1C receptors in the behavioral effects of the 5-HT agonist 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI). Neurosci Lett 115: 74–80
Rauhala P, Idanpaan-Heikkila JJ, Lang A, Tuominen RK, Mannisto PT (1995) Cold exposure attenuates effects of secretagogues on serum prolactin and growth hormone levels in male rats. Am J Physiol 268: E758-E765
Richardson BP, Engel G, Donatsch P, Stadler PA (1985) Identification of serotonin M-receptor subtypes and their specific blockade by a new class of drugs. Nature 316: 126–131
Rittenhouse PA, Bakkum EA, Van de Kar LD (1991) Evidence that the serotonin agonist, DOI, increases renin secretion and blood pressure through both central and peripheral 5-HT2 receptors. J Pharmacol Exp Ther 259: 58–65
Schwartz PJ, Wehr TA, Rosenthal NE, Bartko JJ, Oren DA, Leutke C, Murphy DL (1995) Serotonin and thermoregulation: physiologic and pharmacologic aspects of control revealed by intravenousm-CPP in normal human subjects. Neuropsychopharmacology (in press)
Simansky KJ, Schechter LE (1988) Properties of somel-arylpiperazines as antagonists of stereotyped behaviors mediated by central serotonergic receptors in rodents. J Pharmacol Exp Ther 247: 1073–1081
Titeler M, Lyon RA, Glennon RA (1988) Radioligand binding evidence implicates the brain 5-HT2 receptor as a site of action for LSD and phenylisopropylamine hallucinogens. Psychopharmacology 94: 213–216
Tricklebank MD, Fowler C, Fozard JR (1985) The involvement of subtypes of the 5-HT1 receptor and of catecholaminergic systems in the behavioral response to 8-hydroxy-2-(di-n-propyl-amino)tetralin in the rat. Eur J Pharmacol 106: 271–282
Wang P, Aulakh CS, Hill JL, Murphy DL (1988) Fawn-Hooded rats are subsensitive to the food intake suppressant effects of 5-HT agonists. Psychopharmacology 94: 558–562
Wozniak KM, Aulakh CS, Hill JL, Murphy DL (1988) The effect of 8-OH-DPAT on temperature in the rat and its modification by chronic antidepressant treatments. Pharmacol Biochem Behav 30: 451–456
Wozniak KM, Aulakh CS, Hill JL, Murphy DL (1989) Hyperthermia induced bym-CPP in the rat and its modification by antidepressant treatments. Psychopharmacology 97: 269–274
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Mazzola-Pomietto, P., Aulakh, C.S., Wozniak, K.M. et al. Evidence thatm-chlorophenylpiperazine-induced hyperthermia in rats is mediated by stimulation of 5-HT2C receptors. Psychopharmacology 123, 333–339 (1996). https://doi.org/10.1007/BF02246643
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF02246643